InterAx Biotech AG is a startup based in Switzerland, 1 tracked investor.
InterAx Biotech AG is a company headquartered in Switzerland. Brouky records 1 investor associated with the company.
InterAx Biotech develops novel small molecule drugs targeting GPCRs using its Deep Signal™ platform, which combines mathematical modeling, experimental methods, and machine learning to understand cellular signaling and improve drug efficacy and safety.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.